Mycosis fungoides secondary prevention
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [2]
Overview
There are no established measures for the secondary prevention of mycosis fungoides.
Secondary Prevention
- There are no established measures for the secondary prevention of mycosis fungoides.
- Effective measures for the secondary prevention of mycosis fungoides include:[1][2]
- Effective measures for the secondary prevention of mycosis fungoides is follow up patients with active or progressive disease, every 4–6 weeks.
- Phototherapy (PUVA and involves oral 8-methoxypsoralen) is the preservation in the early stage.
References
- ↑ Santos JL (June 1974). “[Projection of the Brazilian population: 1970-2000]”. Rev Saude Publica (in Portuguese). Suppl: 91–102. PMID 4438970.
- ↑ Willemze, R; Hodak, E; Zinzani, P L; Specht, L; Ladetto, M (2018). “Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†”. Annals of Oncology. 29 (Supplement_4): iv30–iv40. doi:10.1093/annonc/mdy133. ISSN 0923-7534.
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH